Ofatumumab added to dexamethasone in patients with relapsed of refractory chronic lymphocytc leukemia. Results from a phase II study of the czech leukemia study group for life

• Authors: DOUBEK Michael; BRYCHTOVÁ Yvona; PANOVSKÁ Anna; TRIZULJAK J.; ŠEBEJOVÁ Ludmila; STEHLÍKOVÁ Olga; CHOVANCOVÁ Jana; MALČÍKOVÁ Jitka; ŠMARDOVÁ Jana; PLEVOVÁ Karla; VOLFOVÁ Pavlína; TRBUŠEK Martin; MRÁZ Marek; MAJERČÁKOVÁ Denisa; OBRTLÍKOVÁ Petra; KARBAN Josef; SMOLEJ Lukáš; LINDTNEROVÁ Michaela; OLTOVÁ Alexandra; JELÍNKOVÁ Eva; POSPÍŠILOVÁ Šárka; MAYER Jiří
• Year of publication: 2013
• Type: Conference abstract
• MU Faculty or unit: Central European Institute of Technology